Why Wealthy Investors Are Betting Big on AI and HealthTech

Jan de Vries · 2026-10-12

### The EU's Billion-Dollar Bet on AI and HealthTech Europe is making a massive push into artificial intelligence and healthcare. The EU's InvestAI initiative aims to mobilize €200 billion ($216 billion) for AI, including funding for major infrastructure. That's not pocket change—it's a statement. But it's not just AI. The European Commission and the European Investment Bank Group have launched BioTechEU to mobilize €10 billion ($10.8 billion) for biotech and life sciences in 2026 and 2027. This is a coordinated effort to lead in the technologies of the future. ### Why Family Offices Are Following Suit Wealthy private investors are paying attention. According to the UBS Global Family Office Report 2026, 65% of family offices are already invested in AI, and 33% have allocated to AI-enabled healthcare. These are the people who tend to move early—and they're moving in a big way. So why the shift? It's simple: these sectors are where the growth is. And the EU is putting serious money behind them. ### Infrastructure: The Backbone of AI Growth You can't have AI without computing power. In July 2026, the EU requested up to seven AI Gigafactories, backed by up to €10 billion ($10.8 billion) in EU and national funding. These are expected to unlock at least €20 billion ($21.6 billion) in additional private investment. That's a lot of zeros. But it makes sense—AI needs massive computational resources, and Europe is building them. ### Life Sciences: A European Strength Europe has a long history in life sciences. The sector already contributes nearly €1.5 trillion ($1.62 trillion) in value and supports 29 million jobs. Now, through BioTechEU, the EU wants to pour another €10 billion ($10.8 billion) into biotechnology and life sciences during 2026 and 2027. The European Commission's life sciences strategy also includes measures to make multi-country clinical trials easier to fund and €300 million ($324 million) to stimulate procurement of innovations like next-generation vaccines and affordable cancer solutions. ### AI and HealthTech: A Perfect Match The EU isn't just investing in AI and healthcare separately—it's bringing them together. By April 2026, 19 AI Factories had been deployed across European supercomputers, with 13 regional antennas. EU and participating countries have committed more than €2.6 billion ($2.8 billion) to this initiative. On the healthcare side, the European Health Data Space is making health data easier to access and reuse securely. Projects like Cancer Image Europe are expected to provide access to 60 million cancer images by the end of 2026, and the 1+ Million Genomes initiative aims to provide secure access to genomic data. > "The convergence of AI and healthcare is creating unprecedented opportunities for investors who understand both sectors." — Industry expert ### From Lab to Clinic: AI in Real-World Medicine The EU is also pushing AI from research into clinical settings. In 2026, the European Commission made €9 million ($9.7 million) available for two large-scale pilots of AI-powered medical imaging, covering X-rays, CT scans, MRI, PET, and ultrasound. For investors, the attraction is clear: HealthTech is moving beyond the lab into real-world clinical testing and EU-backed deployment programs. That means faster paths to market and potential for significant returns. ### The Bottom Line The EU's investment plans are ambitious, but they're backed by real money and a clear strategy. High-net-worth investors are taking note—and following the capital. If you're looking at where the smart money is going in 2026, AI and HealthTech in Europe should be on your radar. As investment moves into high-growth sectors, investors can also explore private-market opportunities through firms like Top Business Ventures, which operates across venture capital, private equity, and real estate markets. But always do your own due diligence. The opportunities are real, but so are the risks.